Commercialisation of Biomarker Tests for Mental Illnesses: Advances and Obstacles

Commercialisation of Biomarker Tests for Mental Illnesses: Advances and Obstacles Substantial strides have been made in the field of biomarker research for mental illnesses over the past few decades. However, no US FDA-cleared blood-based biomarker tests have been translated into routine clinical practice. Here, we review the challenges associated with commercialisation of research findings and discuss how these challenges can impede scientific impact and progress. Overall evidence indicates that a lack of research funding and poor reproducibility of findings were the most important obstacles to commercialization of biomarker tests. Fraud, pre-analytical and analytical limitations, and inappropriate statistical analysis are major contributors to poor reproducibility. Increasingly, these issues are acknowledged and actions are being taken to improve data validity, raising the hope that robust biomarker tests will become available in the foreseeable future. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Trends in Biotechnology Elsevier

Commercialisation of Biomarker Tests for Mental Illnesses: Advances and Obstacles

Loading next page...
 
/lp/elsevier/commercialisation-of-biomarker-tests-for-mental-illnesses-advances-and-RFiDY4CeeJ
Publisher
Elsevier Current Trends
Copyright
Copyright © 2015 Elsevier Ltd
ISSN
0167-7799
D.O.I.
10.1016/j.tibtech.2015.09.010
Publisher site
See Article on Publisher Site

Abstract

Substantial strides have been made in the field of biomarker research for mental illnesses over the past few decades. However, no US FDA-cleared blood-based biomarker tests have been translated into routine clinical practice. Here, we review the challenges associated with commercialisation of research findings and discuss how these challenges can impede scientific impact and progress. Overall evidence indicates that a lack of research funding and poor reproducibility of findings were the most important obstacles to commercialization of biomarker tests. Fraud, pre-analytical and analytical limitations, and inappropriate statistical analysis are major contributors to poor reproducibility. Increasingly, these issues are acknowledged and actions are being taken to improve data validity, raising the hope that robust biomarker tests will become available in the foreseeable future.

Journal

Trends in BiotechnologyElsevier

Published: Dec 1, 2015

References

  • The economic cost of brain disorders in Europe
    Olesen, J.
  • Applications of blood-based protein biomarker strategies in the study of psychiatric disorders
    Chan, M.K.
  • Biomarkers of psychiatric diseases: current status and future prospects
    Kalia, M.; Costa, E.S.J.
  • A review on the acute phase response in major depression
    Maes, M.
  • Identification of subgroups of schizophrenia patients with changes in either immune or growth factor and hormonal pathways
    Schwarz, E.
  • The promise of biomarkers in diagnosing major depression in primary care: the present and future
    Redei, E.E.; Mehta, N.S.
  • The long journey of cancer biomarkers from the bench to the clinic
    Pavlou, M.P.
  • ELISA and multiplex technologies for cytokine measurement in inflammation and aging research
    Leng, S.X.
  • Antibody-based protein multiplex platforms: technical and operational challenges
    Ellington, A.A.
  • A simulation study of the number of events per variable in logistic regression analysis
    Peduzzi, P.
  • Diagnostic proteomics: will this impact the clinic?
    Sauer, S.
  • Implementation of proteomic biomarkers: making it work
    Mischak, H.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve Freelancer

DeepDyve Pro

Price
FREE
$49/month

$360/year
Save searches from Google Scholar, PubMed
Create lists to organize your research
Export lists, citations
Access to DeepDyve database
Abstract access only
Unlimited access to over
18 million full-text articles
Print
20 pages/month
PDF Discount
20% off